Reps. Erik Paulsen (R-Minn.) and Jim Gerlach (R-Pa.) go to bat for med-tech, calling the FDA's 2.3 percent excise tax a job and innovation killer.

MASSDEVICE ON CALL — Reps. Erik Paulsen (R-Minn.) and Jim Gerlach (R - Pa.) went to bat for medical device makers, urging that the 2.3 percent excise tax set to go into effect in 2013 will hinder innovation in the field.
Paulsen and Gerlach penned a statement on the med-tech levy, saying that the measure will be directly responsible for some 43,000 lost jobs and put American global competitiveness in peril.
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...